Daily news email for August 21, 2012 | Click here for updated news
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)
NIH Translational Center Should Raise All Boats, BIO Says
Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update
Biotechnology to be 21st-century industry: Life Tech CEO
|
Burrill Report
Elan to Shed Drug Discovery Unit
RNA Therapeutics in the Dealmaking Spotlight
Pfizer's Animal Health Unit Zoetis Files IPO
Inching Closer to a Pill for Men
Whistleblower Sues Genentech
|
CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend
New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising
Technology companies adapt interactive video concepts for clinical trial informed consent
CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases
New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
|
New York Times- Pharmaceuticals
Get Antibiotics Off the Farm
Amgen, Citing Weak Results, Halts Study of a Cancer Drug
Pfizer Animal Health Unit Files for I.P.O.
Beware the Nocebo Effect
Amgen, Citing Weak Results, Halts Study of Pancreatic Cancer Drug
|
OnBioVC
Stemgent, Inc.: Series C $6.3M
Genalyte, Inc.: Series A $11.8M
Relievant Medsystems, Inc.: Series D $30M
ImaginAb, Inc.: Series A $12.5M
BiO2 Medical, Inc.: Series B $13.7M
|
Outsourcing-Pharma
Wockhardt targets CMO space for diversification
Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles
Home visits = regulatory thumbs up ResearchNurses.co thinks so
Home visits are the key to patient retention, says ResearchNurses.co
Kemwell and Boehringer set to finish biologics plant in India
|
